[Antibiotic therapy of perforated appendicitis in children: comparison between the amoxicillin-clavulanic acid and the benzylpenicillin-netilmicin-metronidazole combinations].
In a multicentre trial we compared the clinical efficacy of amoxicillin/clavulanate used as a single-agent therapy with that of the three-agent combination usually prescribed in the post-operative period for appendicular peritonitis in children. Only bacteriologically documented peritoneal infections were included. Sixty-four patients were randomly distributed between two groups: Group A (29 cases) treated with amoxicillin/clavulanate, first administered iv (100 mg/kg/d), followed by conversion to the oral route (50 mg/kg/d) once the patient had been afebrile for 48 hours; Group B (35 cases) first treated by the iv route with benzylpenicillin (100,000 IU/kg/d) plus netilmicin (5 mg/kg/d) plus metronidazole (30 mg/kg/d), followed by conversion to the oral route for metronidazole (30 mg/kg/d). In both groups, the total duration of parenteral and oral treatment was not less than 5 days. One hundred and seventy nine bacterial strains were recovered from peritoneal fluid samples obtained during surgery; 86% of these were sensitive to amoxicillin/clavulanate. Clinical efficacy, assessed on the basis of time until return to normal temperature and gut transit and duration of hospitalization, was identical in both groups, with follow-up monitoring on day 30 showing recovery in all cases. Cure was obtained without any problems of infection in 25/29 patients in group A and in 34/35 patients in group B (non significant difference). Tolerance was excellent and identical in the two groups with the exception of three cases of thrombophlebitis which occurred in group B. The results of this study suggest that amoxicillin/clavulanate may be useful as single-agent therapy as a first-line curative treatment for appendicular peritonitis in children.
Service de chirurgie pédiatrique, hôpital des Enfants, Nancy, France.
M
M
Schmitt
J M
JM
Bondonny
P
P
Delmas
R B
RB
Galifer
Y
Y
Revillon
M
M
Robert
D000293:Adolescent; D000658:Amoxicillin / Q000627:therapeutic use; D001064:Appendicitis / Q000188:drug therapy* / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D002969:Clavulanic Acids / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007416:Intestinal Perforation / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D009428:Netilmicin / Q000627:therapeutic use; D010400:Penicillin G / Q000627:therapeutic use; D012422:Rupture, Spontaneous; D013997:Time Factors
D002969:Clavulanic Acids; D008795:Metronidazole; D009428:Netilmicin; D000658:Amoxicillin; D010400:Penicillin G
Antibiothérapie de l'appendicite perforée chez l'enfant: comparaison de l'amoxicilline-acide clavulanique et de l'association benzylpénicilline-nétilmicine-métronidazole.